Ohm20 You might be correct with regards to the fac
Post# of 148170
(Total Views: 524)
Posted On: 06/20/2021 2:47:31 PM
Ohm20 You might be correct with regards to the fact that "a sphingosine kinase-2 inhibitor is not better than a janus kinase inhibitor and puts Opaganib on level with Baractnib, and Japan did shot down the initial application for Favipiravir in Covid-19. but it is my understanding that the trail for approval of both Opaganib and Avigan(R)/Reeqonus(TM) (favipiravir) as a potential oral therapy for patients with mild-to-moderate COVID-19 is still on-going, in fact I am not making a statement based on the possible success or failure of any of these molecules. My statement was FYI (for your information ) in direct response to Post made On: 06/19/2021 1:46:26 PM Posted By: swordman
"There's also no diagnostic test, no specific treatment, no pill to take. And while research is ongoing, there aren't large, peer-reviewed, gold-standard clinical trials yet either. "Read More: https://investorshangout.com/post/view?id=616...z6yM2IkG6P
My response was only to provided with fact based information/evidene in an effort to inform the poster ... in order to help keep the integrity of the information being provided on this form. It is important that poster continues to put forth their best effort to only post accurate information to the best of their knowledge, and if the information is incorrect it should be corrected. I do not like when posters make blanket statements regarding information that may be incorrect it’s important that the information being shared on this message board be as accurate as possible and backed by factual information, unless given as ones opinion but not as fact and if it is an opinion that it should be stated as such (IMOP) and not be interpreted as fact when it is not a factor but just ones opinion.
It is also important that we understand the competitive landscape that we are in relation to other molecules that are targeting the indications (Covid-19) that we are seeking approval for in an effort to have a realistic perspective on the advantages and disadvantages that we might face in our effort to seek approval and accurately value our investment in the molecule and the value of indication that we are seeking approval for.
Regardless I am hoping for more positive information regarding LL next week please have a great father day.
"There's also no diagnostic test, no specific treatment, no pill to take. And while research is ongoing, there aren't large, peer-reviewed, gold-standard clinical trials yet either. "Read More: https://investorshangout.com/post/view?id=616...z6yM2IkG6P
My response was only to provided with fact based information/evidene in an effort to inform the poster ... in order to help keep the integrity of the information being provided on this form. It is important that poster continues to put forth their best effort to only post accurate information to the best of their knowledge, and if the information is incorrect it should be corrected. I do not like when posters make blanket statements regarding information that may be incorrect it’s important that the information being shared on this message board be as accurate as possible and backed by factual information, unless given as ones opinion but not as fact and if it is an opinion that it should be stated as such (IMOP) and not be interpreted as fact when it is not a factor but just ones opinion.
It is also important that we understand the competitive landscape that we are in relation to other molecules that are targeting the indications (Covid-19) that we are seeking approval for in an effort to have a realistic perspective on the advantages and disadvantages that we might face in our effort to seek approval and accurately value our investment in the molecule and the value of indication that we are seeking approval for.
Regardless I am hoping for more positive information regarding LL next week please have a great father day.
(6)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼